Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
Senomyx (NASDAQ: SNMX) - 9.22% - Initiated with Buy ratings at two firms, Craig-Hallum and Lake Street Capital. The former set a $16.50 price target while the latter set a $14 target.
Enbridge Energy Management LLC (NYSE: EEQ) - 11.52% - Announcing an additional 12.6 percent sale of the company's subsidiary Midcoast Operating, L.P. to Midcoast Energy Partners for $350 million in cash. The deal is set to be completed by July 1, 2014.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Measurement Specialties (NASDAQ: MEAS) - 10.45% - After the closing bell Wednesday, TE Connectivity signed a definitive agreement to acquire Measurement Specialties for $1.7 billion in cash.
The Rubicon Project (NYSE: RUBI) - 7.69% - shares have charged through a resistance level at $13. The price consolidated around the $13 level for most of early June, and plunged to test the $12 level upon breaking $13. Prior to Thursday's breakout, the price had been vacillating around $12.
Insys Therapeutics (NASDAQ: INSY) - 8.55% - continuing volatile run this week following a 12 percent move higher on Tuesday and a five percent decline on Wednesday. Shares initially traded higher in sympathy with news out of GW Pharma of promising efficacy and safety for Epidiolex. INSYS shares are moving back over the $30 psychological level during Thursday's session.
Losers
Kellogg, Brown and Root (NYSE: KBR) - 9.80% - The company reported Q1 EPS of $(0.29) which may not compare to the estimated $0.38. Revenue came in at $1.63B which may not compare to the estimated $1.77B. Sales were Down 12 percent year over year.
Northwest Biotherapeutics (NASDAQ: NWBO) -19.25% - The company is accused of violating Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, after issuing a stern rebuke by MD Anderson Cancer Center for making unjustifiable claims concerning the current trail of DCVax-Direct cancer vaccine.
Pier 1 Imports (NYSE: PIR) -13.31% - After missing consensus on its Q1 2014 earnings release earlier today. Earnings for the retailer's recent period came in at $0.16 per share, versus Wall Street's forecast of $0.20. For the upcoming year, the retailer cut its profit outlook to $1.14 to $1.22 per share, from an earlier range of $1.16 to $1.24.
Career Education (NASDAQ: CECO) - 9.36% - The entire education sector is trading lower Thursday following news out of Corinthian Colleges of an inquiry by the Department of Education and language the company may not be able to continue as a going concern if financing is not secured. Shares of Corinthian Colleges are down more than 60 percent at last check.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.